Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
Clinical trial NCT00428090 · COMPLETED
Trial details
- NCT number
- NCT00428090
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-27
- Primary completion
- 2008-09-01
- Enrollment
- 862
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.